Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

被引：8
作者：
Lassen, Ulrik [1 ]
机构：
[1] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark
来源：
LANCET ONCOLOGY | 2020年 / 21卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(19)30789-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：193 / 194
页数：2
相关论文
共 7 条
  • [1] Molecular Pathways: ROS1 Fusion Proteins in Cancer
    Davies, Kurtis D.
    Doebele, Robert C.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4040 - 4045
  • [2] Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
    Doebele, Robert C.
    Drilon, Alexander
    Paz-Ares, Luis
    Siena, Salvatore
    Shaw, Alice T.
    Farago, Anna F.
    Blakely, Collin M.
    Seto, Takashi
    Cho, Byung Chul
    Tosi, Diego
    Besse, Benjamin
    Chawla, Sant P.
    Bazhenova, Lyudmila
    Krauss, John C.
    Chae, Young Kwang
    Barve, Minal
    Garrido-Laguna, Ignacio
    Liu, Stephen V.
    Conkling, Paul
    John, Thomas
    Fakih, Marwan
    Sigal, Darren
    Loong, Herbert H.
    Buchschacher, Gary L., Jr.
    Garrido, Pilar
    Nieva, Jorge
    Steuer, Conor
    Overbeck, Tobias R.
    Bowles, Daniel W.
    Fox, Elizabeth
    Riehl, Todd
    Chow-Maneval, Edna
    Simmons, Brian
    Cui, Na
    Johnson, Ann
    Eng, Susan
    Wilson, Timothy R.
    Demetri, George D.
    [J]. LANCET ONCOLOGY, 2020, 21 (02) : 271 - 282
  • [3] Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
    Drilon, A.
    Laetsch, T. W.
    Kummar, S.
    DuBois, S. G.
    Lassen, U. N.
    Demetri, G. D.
    Nathenson, M.
    Doebele, R. C.
    Farago, A. F.
    Pappo, A. S.
    Turpin, B.
    Dowlati, A.
    Brose, M. S.
    Mascarenhas, L.
    Federman, N.
    Berlin, J.
    El-Deiry, W. S.
    Baik, C.
    Deeken, J.
    Boni, V.
    Nagasubramanian, R.
    Taylor, M.
    Rudzinski, E. R.
    Meric-Bernstam, F.
    Sohal, D. P. S.
    Ma, P. C.
    Raez, L. E.
    Hechtman, J. F.
    Benayed, R.
    Ladanyi, M.
    Tuch, B. B.
    Ebata, K.
    Cruickshank, S.
    Ku, N. C.
    Cox, M. C.
    Hawkins, D. S.
    Hong, D. S.
    Hyman, D. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (08) : 731 - 739
  • [4] Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials
    Drilon, Alexander
    Siena, Salvatore
    Dziadziuszko, Rafal
    Barlesi, Fabrice
    Krebs, Matthew G.
    Shaw, Alice T.
    de Braud, Filippo
    Rolfo, Christian
    Ahn, Myung-Ju
    Wolf, Juergen
    Seto, Takashi
    Cho, Byoung Chul
    Patel, Manish R.
    Chiu, Chao-Hua
    John, Thomas
    Goto, Koichi
    Karapetis, Christos S.
    Arkenau, Hendrick-Tobias
    Kim, Sang-We
    Ohe, Yuichiro
    Li, Yu-Chung
    Chae, Young K.
    Chung, Christine H.
    Otterson, Gregory A.
    Murakami, Haruyasu
    Lin, Chia-Chi
    Tan, Daniel S. W.
    Prenen, Hans
    Riehl, Todd
    Chow-Maneval, Edna
    Simmons, Brian
    Cui, Na
    Johnson, Ann
    Eng, Susan
    Wilson, Timothy R.
    Doebele, Robert C.
    [J]. LANCET ONCOLOGY, 2020, 21 (02) : 261 - 270
  • [5] Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement
    Lim, Sun Min
    Kim, Hye Ryun
    Lee, Jong-Seok
    Lee, Ki Hyeong
    Lee, Yun-Gyoo
    JooMin, Young
    Cho, Eun Kyung
    Lee, Sung Sook
    Kim, Bong-Seog
    Choi, Moon Young
    Shim, Hyo Sup
    Chung, Jin-Haeng
    La Choi, Yoon
    Lee, Min Jeong
    Kim, Maria
    Kim, Joo-Hang
    Ali, Siraj M.
    Ahn, Myung-Ju
    Cho, Byoung Chul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2613 - +
  • [6] Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics
    Okamura, Ryosuke
    Boichard, Amelie
    Kato, Shumei
    Sicklick, Jason K.
    Bazhenova, Lyudmila
    Kurzrock, Razelle
    [J]. JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 20
  • [7] The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib
    Patil, Tejas
    Smith, Derek E.
    Bunn, Paul A.
    Aisner, Dara L.
    Le, Anh T.
    Hancock, Mark
    Purcell, William T.
    Bowles, Daniel W.
    Camidge, D. Ross
    Doebele, Robert C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1717 - 1726
1